An Indigenous public health expert, she creates powerful narratives by merging rigorous research with cultural insight—and ...

Every year, viral respiratory infections place a significant burden on the health care system. The CDC predicts that influenza, respiratory syncytial virus and COVID-19 collectively will account for ...

Crisp weather is popping up across the United States, signalling the start of fall, a new school year and, of course, respiratory virus season. But five years after the emergence of the COVID-19 ...

In late summer, tens of millions of children throughout the United States return to school, sharing tales of their summer adventures and, inevitably, new germs. Many will develop a cough, sore throat, ...

Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX) (Salarius or the Company) announces that on September 4, 2025 the Company received notification from The Nasdaq ...

Your medicine cabinet could be packing more than just cold and flu relief. A groundbreaking new study found that a widely available over-the-counter nasal spray may help healthy adults fend off ...

GSK GSK stock has risen 6.4% over the past month, adding nearly $5 billion to its market value. The consistently strong ...

Detailed price information for United Therapeutic (UTHR-Q) from The Globe and Mail including charting and trades.

Respiratory syncytial virus (RSV) can cause serious illness in older adults. The bivalent RSV prefusion F protein–based vaccine (RSVpreF) has been shown to prevent RSV-associated respiratory illness, ...

In mid-September, the CDC’s Advisory Committee on Immunization Practices will discuss — and potentially vote on — vaccines for COVID-19, hepatitis B, measles, mumps, rubella, varicella, and ...

Citing a “new evidenced based philosophy,” the FDA’s Center for Biologics Evaluation and Research (CBER) is preparing to take a hard line against the common practice of administering certain ...